Aclaris Therapeutics (ACRS) reported Q4 Revenue
Tweet
Share
E-mailGet Alerts ACRS Hot Sheet
Join SI Premium – FREE
Aclaris Therapeutics (NASDAQ: ACRS) reported Q4 Revenue for the quarter came in at $9.21 million versus the consensus estimate of $2.08 million.
For earnings history and earnings-related data on Aclaris Therapeutics (ACRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UGI shares spike on reported KKR bid for the company
- 374Water Inc (SCWO) Misses Q2 EPS by 15c
- Suncrete Inc (RMIX) PT Lowered to $22 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
